To evaluate the efficacy of japakusum Lepa in the management of indralupta with special reference to alopecia areta

Single arm clinical study to assess the efficacy of Japakusum lepa in Indralupta with special refernce to Alopecia Areata - nil

Status

Active, not recruiting

Phases

Phase 1Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/07/091329

Enrollment

Registered

2025-07-21

Start date

Unknown

Completion date

Unknown

Last updated

2025-08-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L638- Other alopecia areata

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1 Patients having signs and symptoms of Indralupta 2 Patient of Indralupta from any community irrespective of their religion socioeconomic status hygiene condition 3 Patient willing to give consent for clinical trial

Exclusion criteria

Exclusion criteria: Patients below 18yrs and above 50 years of age group 2) Patients having systemic disease with complications which can lead to interference with the study 3) Unstable patients 4) Any other local treatment for Indralupta 5) Pregnant women 6) Patient on chemotherapy

Design outcomes

Primary

Measure	Time frame
Evaluation the efficacy of japakusum lepa in IndraluptaTimepoint: 21 days	—

Secondary

Measure	Time frame
To reduce the indralupta in 21 days To study the literature related to concept of indralupta To study the concept of japakusum lepa in indraluptaTimepoint: 21 days	—

Countries

India

Contacts

Public ContactDr Pravin Chavan

LRP Ayurvedic Medical College And Research Centre

drpravin999@gmail.com9822338613

Outcome results